Thinking about stopping Mounjaro for your holiday? Here's what to expect

You're two weeks from your flight and wondering whether to take the pen or leave it at home

This is a question our prescribers hear most weeks in the run-up to summer. The short answer is: taking it with you is almost always the simpler option, and most people do. If you're asking whether you can take Mounjaro on holiday, the answer is yes in most cases, and the pen can sit outside the fridge for a limited period, and with a small insulated pouch and a note from your prescriber, airport security and customs are rarely a problem. If you'd like a full picture of the practical steps involved, the guide to taking Mounjaro on holiday covers storage windows, letter templates and what to declare.

If you've decided a pause is genuinely right for you, it helps to know what's coming. Tirzepatide works by activating both GIP and GLP-1 receptors, which together slow gastric emptying and reduce appetite signals. Those effects don't linger indefinitely once you stop injecting. For most people, appetite begins to return within the first week. By two to three weeks in, the suppression is largely gone. That doesn't mean your holiday will be derailed, but going in expecting to feel exactly as you did on treatment is likely to lead to frustration.

Weight regain during a short break is possible, though how much varies considerably from person to person. For anyone planning ahead, our page on Mounjaro and going on holiday covers the timing and logistics in detail, and the full Mounjaro overview explains how the dose schedule works and why consistency shapes the results over time.

What happens to your body when the doses stop

Tirzepatide has a half-life of roughly five days, so it clears gradually rather than abruptly. In the first few days after your last injection you may notice little difference. Then, typically around day seven to ten, hunger cues tend to become more prominent again. Foods that felt unappealing on treatment may suddenly seem appealing. Portion sizes that felt natural a fortnight ago may feel modest.

None of this is a sign that something has gone wrong. It's the expected pharmacology of stopping a medicine that was actively moderating appetite. The dedicated page on whether stopping is the right call goes into more depth on the decision itself.

The NHS's patient information for tirzepatide notes that Mounjaro should be used alongside a reduced-calorie diet and increased physical activity, the lifestyle foundations don't pause just because the pen does. Keeping up with eating patterns you've built on treatment is genuinely useful during a break, even if appetite is louder.

One consideration that catches people off-guard: if your break extends beyond four to six weeks, restarting at the dose you stopped on may cause more nausea and GI discomfort than you experienced when you first began treatment. Your prescriber may recommend stepping back to an earlier dose and re-titrating, which adds weeks to your overall timeline. A short, planned break rarely requires this. A longer, informal one often does.

The restart conversation: what your prescriber needs to know

Coming back to treatment after a holiday pause isn't simply a case of picking up where you left off. Your prescriber will want to know how long you were off, whether you experienced any symptoms during the break, and what your weight and appetite have done in the interim. At nume, every repeat order goes through a fresh clinical review (a real prescriber reads your update, not an automated system) so the restart is also a checkpoint, not just a refill.

If you stopped for longer than planned, or if the break was prompted by something more than logistics, it's worth being straightforward about that. The FAQs cover some common restart scenarios, and our support team is available seven days a week if you need to speak to someone before your review is due.

It's also worth separating the holiday pause question from a different scenario: stopping Mounjaro ahead of surgery. That involves different clinical reasoning and its own set of anaesthetic considerations. If that applies to you, the stopping before surgery page covers it properly.

What the evidence says about stopping GLP-1 medicines, and what it means for you

Clinical trial data on tirzepatide shows that weight loss achieved during treatment is maintained while the medicine is continued. The corollary is also documented: significant weight regain is common after stopping GLP-1 medicines, particularly over months rather than weeks. A short holiday pause is a different scenario to stopping entirely, but the direction of travel is the same, it just unfolds over a shorter timeframe.

NICE's guidance on tirzepatide (TA1026) frames the medicine as a long-term treatment adjunct, not a short course, which gives useful context for why breaks matter more than they might with some other medicines. You can read NICE's recommendations directly at NICE TA1026.

If you're weighing up the costs of treatment alongside the holiday decision, the treatment and pricing page sets out what's included at nume, one transparent price covering consultation, prescription, delivery and aftercare, with no subscription and no auto-renewal. If you'd like personalised advice on your specific situation, speaking to our prescribers is the most direct route.